As the European Medicines Agency shutters its London office to move to the Netherlands, the high court in England has ruled that the agency remains bound by a property lease for its former headquarters.
The High Court of Justice of England and Wales ruled on 20 February that the EMA has to continue to pay rent for the first 10 floors of a building in London’s Canary Wharf district. The office has been the agency’s headquarters since its creation, but the EU decided the agency should move to Amsterdam because of Brexit.
The agency closed its London office on 1 March. But the lease on the building—which is due to run until 2039 at an estimated cost of £500 million (€582m)—has no break clause.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.